IL6 and breast carcinoma: IL-6 potently promoted the amplification of e-MDSCs and their T cell-suppressive capacity in vitro by activating the STAT/IDO signaling pathway and generating a tryptophan-starved microenvironment that facilitated the evasion of breast cancer cells (8, 9).